Search Results
Dr. Hamlin Discusses Integrating Brentuximab Vedotin
Dr. Fanale Discusses Brentuximab Vedotin in CD30-Positive Lymphomas
Post-transplant survival boosted by brentuximab vedotin in lymphoma
Phase 2 trial of brentuximab vedotin plus AVD for non-bulky limited-stage Hodgkin lymphoma
What is the role of brentuximab vedotin as first line salvage therapy prior to ASCT?
Debate: Recurrent Hodgkin's lymphoma after ASCT in CR on brentuximab vedotin - Maintenance
ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's lymphoma
Dr. Younes Discusses ABVD Versus A+AVD as Front-Line Treatment in Hodgkin Lymphoma
Brentuximab vedotin for advanced Hodgkin lymphoma in the ECHELON-1 study
Facebook Live: Brentuximab vedotin (ADCETRIS®) - Steven Horwitz, MD
Debate: Recurrent Hodgkin's lymphoma after ASCT in CR on brentuximab vedotin - Allotransplant
Novel Antibody Drug Conjugates in Development for Lymphoid Malignancies
